Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Cascione L, Motta G, Fuligni F, Agostinelli C, Rossi M, Sapienza MR, Righi S, Broccoli A, Indio V, Melle F, Tabanelli V, Calleri A, Novero D, Facchetti F, Inghirami G, Sabattini E, Bertoni F, Pileri SA.

Mod Pathol. 2019 Sep 26. doi: 10.1038/s41379-019-0376-8. [Epub ahead of print]

PMID:
31558781
2.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2019 Sep 20. pii: mdz386. doi: 10.1093/annonc/mdz386. [Epub ahead of print] No abstract available.

PMID:
31539020
3.

Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.

Tabanelli V, Corsini C, Fiori S, Agostinelli C, Calleri A, Orecchioni S, Melle F, Motta G, Rotili A, Di Napoli A, Pileri SA.

Hum Pathol. 2019 Aug;90:60-69. doi: 10.1016/j.humpath.2019.05.007. Epub 2019 May 21.

PMID:
31125630
4.

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects.

Sapienza MR, Pileri A, Derenzini E, Melle F, Motta G, Fiori S, Calleri A, Pimpinelli N, Tabanelli V, Pileri S.

Cancers (Basel). 2019 Apr 28;11(5). pii: E595. doi: 10.3390/cancers11050595. Review.

5.

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Cascione L, Motta G, Fuligni F, Agostinelli C, Rossi M, Sapienza MR, Righi S, Broccoli A, Indio V, Melle F, Tabanelli V, Calleri A, Novero D, Facchetti F, Inghirami G, Sabattini E, Bertoni F, Pileri SA.

Mod Pathol. 2019 Apr 25. doi: 10.1038/s41379-019-0279-8. [Epub ahead of print] Erratum in: Mod Pathol. 2019 Sep 26;:.

PMID:
31028364
6.

Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniques.

Pileri SA, Derenzini E, Melle F, Motta G, Calleri A, Antoniotti P, Maltoni V, Spagnolo S, Fiori S, Tabanelli V, Fabbri M.

F1000Res. 2018 Dec 21;7. pii: F1000 Faculty Rev-1966. doi: 10.12688/f1000research.16755.1. eCollection 2018. Review.

7.

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.

Sapienza MR, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, Tabanelli V, Laginestra MA, Pileri A, Motta G, Rossi M, Agostinelli C, Sabattini E, Pimpinelli N, Truni M, Falini B, Cerroni L, Talarico G, Piccioni R, Amente S, Indio V, Tarantino G, Brundu F, Paulli M, Berti E, Facchetti F, Dellino GI, Bertolini F, Tripodo C, Rabadan R, Pileri SA.

Haematologica. 2019 Apr;104(4):729-737. doi: 10.3324/haematol.2018.202093. Epub 2018 Oct 31.

8.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450.

9.

Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders.

De Luca G, Trasarti S, Bizzoni L, Del Giudice I, Della Starza I, De Propris MS, Gentile G, Mancini F, Mantovani S, Petrucci L, Tabanelli V, Guarini A, Vignetti M, Foà R.

Leuk Lymphoma. 2018 Nov;59(11):2715-2718. doi: 10.1080/10428194.2018.1439583. Epub 2018 Feb 23. No abstract available.

PMID:
29473430
10.

Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Facchetti F, Pileri SA, Lorenzi L, Tabanelli V, Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, de Leval L, Rosenwald A, Wotherspoon A, Fend F.

Virchows Arch. 2017 Oct;471(4):467-489. doi: 10.1007/s00428-017-2176-1. Epub 2017 Jul 10.

PMID:
28695297
11.

The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?

Viviani S, Tabanelli V, Pileri SA.

Tumori. 2017 Mar 24;103(2):101-113. doi: 10.5301/tj.5000608. Epub 2017 Feb 22. Review.

PMID:
28233887
12.

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.

Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, Gritti G, Corradini P, Di Nicola M, Patti C, Mulé A, Zanni M, Zoli V, Billio A, Piccin A, Negri G, Castellino C, Di Raimondo F, Ferreri AJ, Benedetti F, La Nasa G, Gini G, Trentin L, Frezzato M, Flenghi L, Falorio S, Chilosi M, Bruna R, Tabanelli V, Pileri S, Masciulli A, Delaini F, Boschini C, Rambaldi A.

J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

13.

Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas.

Laginestra MA, Tripodo C, Agostinelli C, Motta G, Hartmann S, Döring C, Rossi M, Melle F, Sapienza MR, Tabanelli V, Pileri A, Fuligni F, Gazzola A, Mannu C, Sagramoso CA, Lonardi S, Lorenzi L, Bacci F, Sabattini E, Borges A, Simonitsch-Klupp I, Cabecadas J, Campo E, Rosai J, Hansmann ML, Facchetti F, Pileri SA.

Mol Cancer Res. 2017 May;15(5):541-552. doi: 10.1158/1541-7786.MCR-16-0301. Epub 2017 Jan 27.

14.

Pelvic myeloid sarcoma: a multidisciplinary approach.

Seracchioli R, Geraci E, Paradisi R, Montanari G, Zannoni L, Tabanelli V, Pileri SA, Carloni S, Sartor C, Martinelli G.

Eur J Gynaecol Oncol. 2017;38(3):476-478.

PMID:
29693897
15.

Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?

Tabanelli V, Santiago-Pacheco V, Corbellino M, Calleri A, Agostinelli C, Parravicini C, Pileri SA.

Histopathology. 2017 Mar;70(4):650-656. doi: 10.1111/his.13109. Epub 2016 Dec 20.

PMID:
27782313
16.

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

Zaja F, Tabanelli V, Agostinelli C, Calleri A, Chiappella A, Varettoni M, Luigi Zinzani P, Volpetti S, Sabattini E, Fanin R, Pileri SA.

Am J Hematol. 2017 Jan;92(1):E1-E2. doi: 10.1002/ajh.24571. Epub 2016 Nov 10. No abstract available.

17.

Sclerosing angiomatoid nodular transformation of the spleen during pregnancy: Diagnostic challenges and clinical management.

Corrado G, Tabanelli V, Biffi R, Petralia G, Tinelli A, Peccatori FA.

J Obstet Gynaecol Res. 2016 Aug;42(8):1021-5. doi: 10.1111/jog.13008. Epub 2016 Apr 14.

PMID:
27080826
18.

Enteropathy-associated T-cell lymphoma in childhood: a case report and review of the literature.

Chisini M, Bacci F, de Propris MS, Barberi W, Guarini A, Iori AP, Tabanelli V, Moleti ML, Casciani E, Foà R, Testi AM.

Leuk Lymphoma. 2015;56(9):2743-6. doi: 10.3109/10428194.2015.1009059. Epub 2015 Feb 9. Review. No abstract available.

PMID:
25629982
19.

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, Sapienza MR, Motta G, Gazzola A, Mannu C, Sabattini E, Bacci F, Tabanelli V, Sacchetti CA, Barrese TZ, Etebari M, Melle F, Clò A, Gibellini D, Tripodo C, Inghirami G, Croce CM, Pileri SA.

Blood Cancer J. 2014 Nov 7;4:259. doi: 10.1038/bcj.2014.78.

20.

A unique case of an indolent myometrial T-cell lymphoproliferative disorder with phenotypic features resembling uterine CD8+ resident memory T cells.

Tabanelli V, Valli R, Righi S, Nucera G, Zecchini Barrese T, Pileri S, Sabattini E.

Pathobiology. 2014;81(4):176-82. doi: 10.1159/000363346. Epub 2014 Aug 14.

PMID:
25138577
21.

Molecular genetics of peripheral T-cell lymphomas.

Piccaluga PP, Tabanelli V, Pileri SA.

Int J Hematol. 2014 Mar;99(3):219-26. doi: 10.1007/s12185-014-1522-1. Epub 2014 Jan 31. Review.

PMID:
24481943
22.

Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.

Barraco D, Carobolante F, Candoni A, Simeone E, Piccaluga P, Tabanelli V, Fanin R.

Eur J Haematol. 2014 Jun;92(6):541-5. doi: 10.1111/ejh.12272. Epub 2014 Feb 19.

PMID:
24460680
23.

CD30 expression in peripheral T-cell lymphomas.

Sabattini E, Pizzi M, Tabanelli V, Baldin P, Sacchetti CS, Agostinelli C, Zinzani PL, Pileri SA.

Haematologica. 2013 Aug;98(8):e81-2. doi: 10.3324/haematol.2013.084913. Epub 2013 May 28. Review. No abstract available.

24.

Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature.

Tabanelli V, Agostinelli C, Sabattini E, Gazzola A, Bacci F, Capria S, Mannu C, Righi S, Sista MT, Meloni G, Pileri SA, Piccaluga PP.

J Med Case Rep. 2011 Jun 7;5:218. doi: 10.1186/1752-1947-5-218.

Supplemental Content

Loading ...
Support Center